APA

Bot I., von der Thüsen J. H., Donners M. M. P. C., Lucas A., Fekkes M. L., de Jager S. C. A., Kuiper J., Daemen M. J. A. P., van Berkel T. J. C., Heeneman S. & Biessen E. A. L. (20031010). Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. : Circulation research.

Chicago

Bot Ilze, von der Thüsen Jan H, Donners Marjo M P C, Lucas Alexandra, Fekkes Madelon L, de Jager Saskia C A, Kuiper Johan, Daemen Mat J A P, van Berkel Theo J C, Heeneman Sylvia and Biessen Erik A L. 20031010. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. : Circulation research.

Harvard

Bot I., von der Thüsen J. H., Donners M. M. P. C., Lucas A., Fekkes M. L., de Jager S. C. A., Kuiper J., Daemen M. J. A. P., van Berkel T. J. C., Heeneman S. and Biessen E. A. L. (20031010). Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. : Circulation research.

MLA

Bot Ilze, von der Thüsen Jan H, Donners Marjo M P C, Lucas Alexandra, Fekkes Madelon L, de Jager Saskia C A, Kuiper Johan, Daemen Mat J A P, van Berkel Theo J C, Heeneman Sylvia and Biessen Erik A L. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice. : Circulation research. 20031010.